These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 26945496)

  • 21. Safety of angiotensin-converting enzyme inhibitors while receiving venom immunotherapy.
    White KM; England RW
    Ann Allergy Asthma Immunol; 2008 Oct; 101(4):426-30. PubMed ID: 18939733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural history and long-term follow-up of Hymenoptera allergy.
    Ruëff F
    Curr Opin Allergy Clin Immunol; 2020 Oct; 20(5):445-451. PubMed ID: 32739977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical features, severity, and immunological changes during venom immunotherapy in children and adults.
    Buyuktiryaki B; Hela F; Ozturk AB; Dursun AB; Donmez H; Gelincik A; Yegit OO; Yavuz ST; Sahiner UM; Albayrak O; Damadoglu E; Erdogan T; Firtina S; Taylan D; Soyer O; Karakaya G; Kalyoncu AF; Sekerel B; Sackesen C
    Allergy Asthma Proc; 2024 Jul; 45(4):276-283. PubMed ID: 38982596
    [No Abstract]   [Full Text] [Related]  

  • 24. Outcomes of allergy to insect stings in children, with and without venom immunotherapy.
    Golden DB; Kagey-Sobotka A; Norman PS; Hamilton RG; Lichtenstein LM
    N Engl J Med; 2004 Aug; 351(7):668-74. PubMed ID: 15306668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venom immunotherapy for preventing allergic reactions to insect stings.
    Boyle RJ; Elremeli M; Hockenhull J; Cherry MG; Bulsara MK; Daniels M; Oude Elberink JN
    Cochrane Database Syst Rev; 2012 Oct; 10(10):CD008838. PubMed ID: 23076950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insect Venom Immunotherapy: Analysis of the Safety and Tolerance of 3 Buildup Protocols Frequently Used in Spain.
    Gutiérrez Fernández D; Moreno-Ancillo A; Fernández Meléndez S; Domínguez-Noche C; Gálvez Ruiz P; Alfaya Arias T; Carballada González F; Alonso Llamazares A; Marques Amat L; Vega Castro A; Antolín Amérigo D; Cruz Granados S; Ruiz León B; Sánchez Morillas L; Fernández Sánchez J; Soriano Gomis V; Borja Segade J; Dalmau Duch G; Guspi Bori R; Miranda Páez A
    J Investig Allergol Clin Immunol; 2016; 26(6):366-373. PubMed ID: 27996943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and treatment of Hymenoptera venom allergy: S2k Guideline of the German Society of Allergology and Clinical Immunology (DGAKI) in collaboration with the Arbeitsgemeinschaft für Berufs- und Umweltdermatologie e.V. (ABD), the Medical Association of German Allergologists (AeDA), the German Society of Dermatology (DDG), the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNOKC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Allergy and Environmental Medicine (GPA), German Respiratory Society (DGP), and the Austrian Society for Allergy and Immunology (ÖGAI).
    Ruëff F; Bauer A; Becker S; Brehler R; Brockow K; Chaker AM; Darsow U; Fischer J; Fuchs T; Gerstlauer M; Gernert S; Hamelmann E; Hötzenecker W; Klimek L; Lange L; Merk H; Mülleneisen NK; Neustädter I; Pfützner W; Sieber W; Sitter H; Skudlik C; Treudler R; Wedi B; Wöhrl S; Worm M; Jakob T
    Allergol Select; 2023; 7():154-190. PubMed ID: 37854067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hymenoptera venom allergy.
    Przybilla B; Ruëff F
    J Dtsch Dermatol Ges; 2010 Feb; 8(2):114-27; quiz 128-30. PubMed ID: 19751222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Venom immunotherapy in patients with clonal mast cell disorders: efficacy, safety, and practical considerations.
    Bonadonna P; Gonzalez-de-Olano D; Zanotti R; Riccio A; De Ferrari L; Lombardo C; Rogkakou A; Escribano L; Alvarez-Twose I; Matito A; Vega A; Passalacqua G
    J Allergy Clin Immunol Pract; 2013; 1(5):474-8. PubMed ID: 24565619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deliberate hymenoptera sting challenge as a diagnostic tool in highly selected venom-allergic patients.
    Goldberg A; Confino-Cohen R; Mekori YA
    Ann Allergy Asthma Immunol; 1995 Jul; 75(1):30-2. PubMed ID: 7621057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice.
    Bonifazi F; Jutel M; Biló BM; Birnbaum J; Muller U;
    Allergy; 2005 Dec; 60(12):1459-70. PubMed ID: 16266376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survey of patients after discontinuing venom immunotherapy.
    Golden DB; Kagey-Sobotka A; Lichtenstein LM
    J Allergy Clin Immunol; 2000 Feb; 105(2 Pt 1):385-90. PubMed ID: 10669863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of Ultrarush Venom Immunotherapy: Comparison Between Children and Adults.
    Nittner-Marszalska M; Cichocka-Jarosz E; Małaczyńska T; Kraluk B; Rosiek-Biegus M; Kosinska M; Pawłowicz R; Lis G
    J Investig Allergol Clin Immunol; 2016; 26(1):40-7. PubMed ID: 27012015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical Algorithms: Diagnosis and treatment of Hymenoptera venom allergy.
    Sturm GJ; Arzt-Gradwohl L; Varga EM
    Allergy; 2019 Oct; 74(10):2016-2018. PubMed ID: 30972798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hymenoptera stings in the head region induce impressive, but not severe sting reactions.
    Arzt L; Bokanovic D; Schwarz I; Schrautzer C; Massone C; Horn M; Aberer W; Sturm G
    Allergy; 2016 Nov; 71(11):1632-1634. PubMed ID: 27346882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerated sting challenge in patients on Hymenoptera venom immunotherapy improves health-related quality of life.
    Koschel DS; Schmies M; Weber CN; Höffken G; Balck F
    J Investig Allergol Clin Immunol; 2014; 24(4):226-30. PubMed ID: 25219104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life in parents of children and adolescents after systemic sting reactions.
    Cichocka-Jarosz E; Brzyski P; Tarczoń I; Jedynak-Wąsowicz U; Tomasik T; Lis G
    Ann Agric Environ Med; 2019 Jun; 26(2):315-321. PubMed ID: 31232065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subsequent insect stings in children with hypersensitivity to Hymenoptera.
    Hauk P; Friedl K; Kaufmehl K; Urbanek R; Forster J
    J Pediatr; 1995 Feb; 126(2):185-90. PubMed ID: 7844663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of immunotherapy with venom in children with allergy to insect stings.
    Valentine MD; Schuberth KC; Kagey-Sobotka A; Graft DF; Kwiterovich KA; Szklo M; Lichtenstein LM
    N Engl J Med; 1990 Dec; 323(23):1601-3. PubMed ID: 2098016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of clinical effectiveness of Hymenoptera venom immunotherapy.
    Ruëff F; Vos B; Oude Elberink J; Bender A; Chatelain R; Dugas-Breit S; Horny HP; Küchenhoff H; Linhardt A; Mastnik S; Sotlar K; Stretz E; Vollrath R; Przybilla B; Flaig M
    Clin Exp Allergy; 2014; 44(5):736-46. PubMed ID: 24447114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.